Results 131 to 140 of about 26,143 (169)

[Effect of clonal hematopoiesis in remission on hematopoiesis recovery in patients with NPM1 mutated acute myeloid leukemia after chemotherapy]. [PDF]

Zhonghua Xue Ye Xue Za Zhi, 2023
Wang LL, Chen SN.
europepmc   +1 more source

[Analysis of Efficacy and Safety of Neoadjuvant Immunochemotherapy in Patients
with Stage IB-IIIB Non-small Cell Lung Cancer]. [PDF]

Zhongguo Fei Ai Za Zhi
Li Z, Wang X, Wang Y, Cui Z, Wang X, Li X, Jiang G, Wang X.   +7 more
europepmc   +1 more source

[A pan-cancer analysis of PYCR1 and its predictive value for chemotherapy and immunotherapy responses in bladder cancer]. [PDF]

Nan Fang Yi Ke Da Xue Xue Bao
Li Y, Song X, Sun R, Dong X, Liu H.
europepmc   +1 more source

[Circ_EPHB4 regulates temozolomide sensitivity in glioma cells through the miR-424-5p/Wnt3 axis]. [PDF]

Nan Fang Yi Ke Da Xue Xue Bao
Liao Y, Liu J, Liu B, Fei X, Jin C.
europepmc   +1 more source

初治转移性鼻咽癌预后因素及治疗模式探讨

Zhongshan Daxue xuebao. Yixue kexue ban, 2014
摘 要: 【目的】 回顾性分析230例初治转移鼻咽癌的独立预后因素以及治疗模式,筛选出预后较好亚组,从而提高治疗效果?【方法】 选择230例符合入组标准的初治鼻咽癌转移病例纳入本研究,中位年龄48岁,最常见的转移部位为骨(67.0%)?肝(32.6%)?肺(15.7%)等,全部患者至少接受1个疗程的以铂类为基础的联合化疗,中位化疗周期为5个,将预后不利因素纳入多因素Cox比例风险回归模型中分析? 【结果】 全组中位随访时间为21个月,中位生存时间为24个月,3年?5年总生存率分别为27.8%?16.7%?
doaj  

[Formulation of the Best Practice Evidence-Based Nutrition Management Protocol for Nasopharyngeal Carcinoma Patients Undergoing Chemoradiotherapy]. [PDF]

Sichuan Da Xue Xue Bao Yi Xue Ban
Cheng Y, Liu H, Ma Y, Yang T, Hu W.
europepmc   +1 more source

[Study on the indication of concurrent chemoradiotherapy for locally advanced laryngeal carcinoma]. [PDF]

Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi, 2022
Wang W, Huangfu H, Hou Y, Feng Y, Zhang C, Zhai S, Li M.   +6 more
europepmc   +1 more source

[Clinical characteristics and prognosis of chronic disseminated candidiasis in children with acute leukemia following chemotherapy: a multicenter clinical study]. [PDF]

Zhongguo Dang Dai Er Ke Za Zhi
Jiang XH, Liu PJ, Wu CP, Weng KZ, Zhuang SQ, Huang SX, Wang XF, Zheng YZ.   +7 more
europepmc   +1 more source

[Rituximab combined with intensive immunochemotherapy for sporadic adult Burkitt lymphoma: efficacy and prognosis analyse]. [PDF]

Zhonghua Xue Ye Xue Za Zhi
Dong CM, Zou HS, Zhang W, Liu W, Wang Y, Liu HM, Xie T, Li H, Wang Q, Huang WY, Yi SH, An G, Qiu LG, Zou DH.   +13 more
europepmc   +1 more source

Erlotinib in Patients with Brain Metastases for Non-small Cell Lung Cancer [PDF]

, 2009
Jiandong ZHANG, Jinming YU, Xinshuang YU
core